Table 4.
Comparison of SARI patients with RSV to those with a non-RSV or to those with no respiratory virus identified
| Characteristic | RSV-positive (n = 485) N (%) | Other Viruses Positive (n = 590) N (%) | P* | No virus Identified (n = 2132) N (%) |
P$ |
|---|---|---|---|---|---|
| Gender | |||||
| Female | 257 (53) | 312 (53) | 0.203 | 810 (38) | 0.000 |
| Male | 228 (47) | 278 (47) | 1,322 (62) | ||
| Age | |||||
| Below 18 y | 470 (97) | 511 (87) | 0.801 | 1,493 (70) | 0.373 |
| Above 18 y | 15 (3) | 79 (13) | 639 (30) | ||
| Symptom onset ≤7 days | 456 (94) | 480 (81) | 0.064 | 1,211 (57) | 0.250 |
| Cough | 485 (100) | 536 (91) | 0.882 | 2,132 (100) | 1.000 |
| SOB | 485 (100) | 548 (93) | 1.000 | 1,555 (73) | 0.077 |
| Fever | 485 (100) | 590 (100) | 1.000 | 2,132 (100) | 1.000 |
| Sore throat | 174 (36) | 311 (53) | 0.000 | 654 (31) | 0.000 |
| Sputum production | 254 (52) | 312 (53) | 1.000 | 1,169 (55) | 0.870 |
| Body aches | 60 (12) | 105 (18) | 0.063 | 153 (7) | 0.004 |
| Tachypnea | 442 (91) | 558 (95) | 0.063 | 1,732 (81) | 0.087 |
| Nasal congestion | 322 (66) | 325 (55) | 1.000 | 300 (14) | 0.060 |
| Wheezing | 414 (85) | 467 (79) | 0.031 | 360 (17) | 0.063 |
| Abnormal BS | 239 (49) | 319 (54) | 0.008 | 955 (45) | 0.022 |
| Nausea or vomiting | 54 (11) | 62 (10) | 0.988 | 209 (10) | 0.003 |
| Convulsions | 44 (10) | 64 (11) | 0.677 | 63 (3) | 0.046 |
| pneumonia | 13 (3) | 16 (3) | 1.000 | 175 (8) | 0.001 |
| Chronic lung disease | 227 (47) | 233 (39) | 0.086 | 343 (16) | 0.001 |
| Cardiac disease | 81 (17) | 133 (23) | 0.063 | 512 (24) | 0.022 |
| Endocrine disease | 50 (10) | 74 (13) | 0.866 | 147 (7) | 0.002 |
| Renal disease | 5 (1) | 6 (1) | 1.000 | 43 (2) | 0.246 |
| Neuromuscular disorder | 30 (6) | 60 (10) | 0.333 | 176 (8) | 0.033 |
| ICU | 82 (17) | 137 (23) | 0.121 | 606 (28) | 0.000 |
| Ventilation | 43 (9) | 57 (10) | 0.473 | 221 (10) | 0.343 |
| ARDS | 8 (1) | 7 (1) | 1.000 | 3 (0) | 0.000 |
| Respiratory Failure | 9 (2) | 13 (2) | 0.988 | 45 (2) | 1.000 |
| Death | 12 (2) | 12 (2) | 1.000 | 106 (5) | 0.000 |
*P for comparison for SARI patients with a positive result for RSV (RSV-positive SARI patients) and a reference group of tested SARI patients with a negative result for RSV (non-RSV-positive SARI patients).P$ for comparison between RSV-positive SARI patients and non-infected individuals (SARI-negative individuals); RSV Respiratory syncytial virus, SOB Shortness of breath, ICU Intensive care unit, ARDS Acute respiratory distress syndrome